D.B. Root & Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-18,934
| Closed | -$1.21M | – | 171 |
|
2023
Q2 | $1.21M | Buy |
18,934
+297
| +2% | +$19K | 0.46% | 60 |
|
2023
Q1 | $1.29M | Buy |
18,637
+1,068
| +6% | +$74K | 0.51% | 49 |
|
2022
Q4 | $1.26M | Buy |
17,569
+384
| +2% | +$27.6K | 0.53% | 44 |
|
2022
Q3 | $1.22M | Sell |
17,185
-553
| -3% | -$39.3K | 0.56% | 44 |
|
2022
Q2 | $1.37M | Sell |
17,738
-121
| -0.7% | -$9.31K | 0.59% | 41 |
|
2022
Q1 | $1.3M | Buy |
17,859
+442
| +3% | +$32.3K | 0.49% | 52 |
|
2021
Q4 | $1.09M | Buy |
17,417
+418
| +2% | +$26K | 0.39% | 59 |
|
2021
Q3 | $1.01M | Buy |
16,999
+224
| +1% | +$13.2K | 0.39% | 60 |
|
2021
Q2 | $1.12M | Buy |
16,775
+131
| +0.8% | +$8.75K | 0.42% | 54 |
|
2021
Q1 | $1.05M | Sell |
16,644
-99
| -0.6% | -$6.25K | 0.41% | 57 |
|
2020
Q4 | $1.04M | Sell |
16,743
-1,103
| -6% | -$68.4K | 0.41% | 61 |
|
2020
Q3 | $1.08M | Sell |
17,846
-536
| -3% | -$32.3K | 0.43% | 54 |
|
2020
Q2 | $1.08M | Buy |
18,382
+169
| +0.9% | +$9.93K | 0.47% | 51 |
|
2020
Q1 | $1.02M | Buy |
18,213
+1,489
| +9% | +$83K | 0.51% | 49 |
|
2019
Q4 | $1.07M | Sell |
16,724
-463
| -3% | -$29.7K | 0.47% | 61 |
|
2019
Q3 | $871K | Sell |
17,187
-253
| -1% | -$12.8K | 0.41% | 73 |
|
2019
Q2 | $790K | Sell |
17,440
-1,040
| -6% | -$47.1K | 0.35% | 81 |
|
2019
Q1 | $882K | Sell |
18,480
-5,584
| -23% | -$267K | 0.38% | 77 |
|
2018
Q4 | $1.25M | Sell |
24,064
-281
| -1% | -$14.6K | 0.62% | 44 |
|
2018
Q3 | $1.51M | Sell |
24,345
-333
| -1% | -$20.7K | 0.67% | 31 |
|
2018
Q2 | $1.37M | Buy |
24,678
+257
| +1% | +$14.2K | 0.64% | 33 |
|
2018
Q1 | $1.55M | Buy |
24,421
+6,920
| +40% | +$438K | 0.82% | 25 |
|
2017
Q4 | $1.07M | Buy |
+17,501
| New | +$1.07M | 0.92% | 30 |
|